Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism

NCT02604238 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Pulmonary Embolism

Interventions

DRUG: Alteplase

Sponsor

Azienda U.S.L. 1 di Massa e Carrara